NCT03672617View on ClinicalTrials.gov

Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy

CompletedOBSERVATIONAL
Enrollment

321

Participants

Timeline

Start Date

October 2, 2018

Primary Completion Date

April 25, 2019

Study Completion Date

April 25, 2019

Conditions
Growth Hormone Deficiency in Children
Interventions
OTHER

No treatment given

"No treatment is given to study participants. Only evaluation of a questionnaire assessing reasons for non-adherence to growth hormone therapy (GHT) and to determine its validity and reliability.~The preliminary working title of the questionnaire GHCQ used in the outcome measures was renamed for simplicity reasons into BAR-GHT (abbreviation for barriers to growth hormone therapy) after study completion."

Trial Locations (1)

Unknown

Novo Nordisk Investigational Site, Mainz

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT03672617 - Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy | Biotech Hunter | Biotech Hunter